InvestorsHub Logo
Followers 3
Posts 119
Boards Moderated 0
Alias Born 03/02/2013

Re: HankVerde post# 148738

Thursday, 02/25/2021 4:19:44 PM

Thursday, February 25, 2021 4:19:44 PM

Post# of 232564
Thanks Hank,

When investing in any biotech, I always try to look at the worst case scenario, do my DD with a little gut feeling throw in. As I stated, even if the CD12 fails, there is still the HIV trial that has been completed and just needs the BLA filed and that is as close to a sure thing as any other biotech out there. I also thought about HGEN when the price was running parallel to CYDY post reverse split, but I kept getting a feeling of something not being right on that one, hope I am wrong, but I still get the feeling that things are not adding up. Their drug is a GM-CSF similar to the GSK drug that failed in trials and was only successful with patients over 70.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News